Table 2.
Demographic and clinical characteristics by study site.
| Conakry, Guinea | Kitgum, Uganda* | Arua, Uganda | Homa Bay Kenya | Douala Cameroun | Baraka, DRC* | Total** | |
|---|---|---|---|---|---|---|---|
| Study period | August 2011–October 2012 | September 2011–April 2012 | July 2012–January 2013 | August 2012–February 2013 | August 2013–February 2014 | October 2012–January 2015 | |
| Total tested at site | |||||||
| Total, n | 2033 | 3159 | 2971 | 1003 | 1239 | 3610 | 14,015 |
| Positive, n (%) | 574 (28.2) | 332 (10.5) | 386 (13.0) | 372 (37.1) | 396 (32.0) | 288 (8.0) | 2348 (16.8) |
| Negative, n (%) | 1447 (71.2) | 2827 (89.5) | 2585 (87.0) | 617 (61.5) | 826 (66.7) | 3252 (90.1) | 11,554 (82.4) |
| Inconclusive, n (%) | 12 (0.6) | 0 (0.0) | 0 (0.0) | 14 (1.4) | 17 (1.4) | 70 (1.9) | 113 (0.8) |
| Offered to participate | |||||||
| Total, n | 724 | 565 | 750 | 735 | 513 | 559 | 3846 |
| Reasons for non-inclusion | |||||||
| Offered to participate; total, n | 724 | 565 | 750 | 735 | 513 | 559 | 3846 |
| Insufficient sample | 260 | 0 | 22 | 3 | 11 | 0 | 296 |
| Refusal to participate | 8 | 74 | 285 | 232 | 34 | 62 | 695 |
| Excluded due to anaemia | 4 | 0 | 0 | 0 | 0 | 0 | 4 |
| Protocol violation | 0 | 49 | 0 | 0 | 0 | 0 | 49 |
| Unknown/Other | 6 | 4 | 0 | 0 | 6 | 0 | 16 |
| Included in the study | |||||||
| Total, n | 446 | 438 | 443 | 500 | 462 | 497 | 2786 |
| Age and gender | |||||||
| Median age (IQR) | 29 (22–39) | 30 (24–39) | 29 (23–37) | 30 (23–40) | 31 (25–41) | 30 (23–39) | 30 (24–39) |
| Males, n (%) | 132 (29.6) | 176 (40.3) | 213 (48.2) | 201 (40.2) | 163 (35.3) | 177 (35.6) | 1062 (38.1) |
| Entry mode | |||||||
| Volontary testing, n (%) | 0 (0) | 323 (73.90) | 443 (100) | 459 (91.8) | 211 (45.7) | 187 (37.8) | 1623 (58.3) |
| Spouse, n (%) | 238 (53.4) | 20 (4.6) | 0 (0) | 0 (0) | 251 (54.3) | 10 (2.0) | 519 (18.6) |
| Referred – TB clinic, n (%) | 57 (12.8) | 2 (0.5) | 0 (0) | 21 (4.2) | 0 (0) | 3 (0.6) | 83 (3.0) |
| Referred – IPD, n (%) | 33 (7.4) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 297 (59.8) | 330 (11.9) |
| Referred – OPD, n (%) | 13 (2.9) | 33 (7.5) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 46 (1.7) |
| ANC, n (%) | 105 (23.3) | 54 (12.4) | 0 (0) | 20 (4.0) | 0 (0) | 0 (0) | 179 (6.4) |
| Other, n (%) | 0 (0) | 5 (1.1) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 5 (0.2) |
HTC: HIV Testing and Counseling; ANC: Antenatal Care; DRC: Democratic Republic of Congo.
* Not the Local/National/Ministry of Health standard algorithm has been used in this calculation but an algorithm adjusted by MSF according to previous research on diagnostic accuracy of available HIV tests.
**The figures from the algorithm used by MSF in Kitgum and Baraka have been used to calculate the totals.